Editorial

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Editorial

The articles in this year's Americas IP Focus show a region in a state of flux. Nearly all the pieces in the supplement indicate a push towards change and development.

Mexico is clearly grappling with a number of issues in the IP arena, and many of the articles in this supplement concern the jurisdiction. The article on non-traditional trademarks mirrors a worldwide preoccupation with the topic. Other pieces relating to Mexico focus on pitfalls in the Mexican IP system, the conflict between the reservation of rights and trademark law and a comparison between the Mexican approach to patent eligibility and the American guidelines.

The article on three-dimensional trademarks in Peru and other Andean Community countries gives some interesting examples of brands that have been able to register 3D marks. It also details the process for gaining registration of such marks.

One of the articles on Brazil discusses the patent backlog in the country and examines the measures being taken to mitigate this problem. This is a key development in the Brazilian IP sphere. The second piece on Brazil concerns the patent enforcement system in the pharmaceutical industry and analyses recent cases involving injunctions.

Finally, the Canada piece examines the latest developments in IP law in the jurisdiction, showing a move towards better use and protection of IP.

I have no doubt that those with business interests in the Americas will find this supplement invaluable when negotiating the fluid and dynamic IP landscape in this region of the world.

Sanjana Kapila

Commercial projects editor


more from across site and SHARED ros bottom lb

More from across our site

190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Publication of the UPC’s annual report and adoption of the procedural rules of the Patent Mediation and Arbitration Centre were also among major developments
With the INTA Annual Meeting drawing to a close, we asked attendees for their top tips on how to close business after a meeting
Gift this article